Year End Global Trends in Biopharma Transactions Report

Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our goal is to bring value to you and your company. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal landscape.

In this report you can find an overview and analysis of the following across the biopharma market in the US, Europe, and Asia (Japan and China):

Key performance indicators for the life science market
IPO and private financing activity and performance
Deal activity for strategic partnership and M&A
A look ahead and our predictions of the future




Want to change how you receive these emails?
You can update your preference or unsubscribe from this list
Privacy Policy